Could Low-Dose Ketamine Be a Treatment for ADNP Syndrome in Children?
Low-dose ketamine may be a viable treatment option for symptoms of activity-dependent neuroprotective protein syndrome in children.
United States Icahn School Of Medicine At Mount Sinai Human Genetics Icahn School Mount Sinai Sleep Habits Questionnaire
Source: psychiatryadvisor.com